Clinical Trial Update: Safety and Efficacy of Multiple Dosing Regimens of BPS804 in Post Menopausal Women With Low Bone Mineral Density [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating multiple dosing regimens of BPS804 in postmenopausal women with low bone mineral density (osteopenia/osteoporosis).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopenia
• Osteoporosis

Drugs mentioned

• BPS804

Snippet

Sponsor: Ultragenyx Pharmaceutical Inc | Conditions: Osteopenia, Osteoporosis | Phase 2 | Status: COMPLETED